Cargando…

Evaluation and Comparison of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) as Vectors to Develop Hydrochlorothiazide Effective and Safe Pediatric Oral Liquid Formulations

The aim of this study was the optimization of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) in terms of physicochemical and biopharmaceutical properties, to develop effective and stable aqueous liquid formulations of hydrochlorothiazide, suitable for paediatric therapy, ove...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mura, Paola, Maestrelli, Francesca, D’Ambrosio, Mario, Luceri, Cristina, Cirri, Marzia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8063941/ https://www.ncbi.nlm.nih.gov/pubmed/33804945 http://dx.doi.org/10.3390/pharmaceutics13040437

Ejemplares similares

Drug Delivery of Solid Lipid Nanoparticles (SLNs) and Nanostructured Lipid Carriers (NLCs) to Target Brain Tumors
por: Mehrdadi, Soheil
Publicado: (2023)

Combined Approach of Cyclodextrin Complexationand Nanostructured Lipid Carriers for the Development of a Pediatric Liquid Oral Dosage Form of Hydrochlorothiazide
por: Cirri, Marzia, et al.
Publicado: (2018)

Design, characterization and in vivo evaluation of nanostructured lipid carriers (NLC) as a new drug delivery system for hydrochlorothiazide oral administration in pediatric therapy
por: Cirri, Marzia, et al.
Publicado: (2018)

Nanostructured lipid carriers (NLCs) as drug delivery platform: Advances in formulation and delivery strategies
por: Elmowafy, Mohammed, et al.
Publicado: (2021)

Design, Evaluation and Comparison of Nanostructured Lipid Carriers and Chitosan Nanoparticles as Carriers of Poorly Soluble Drugs to Develop Oral Liquid Formulations Suitable for Pediatric Use
por: Nerli, Giulia, et al.
Publicado: (2023)

Formulation And Evaluation Of Nanostructured Lipid Carriers (NLCs) Of 20(S)-Protopanaxadiol (PPD) By Box-Behnken Design
por: Kim, Min-Hwan, et al.
Publicado: (2019)

Atorvastatin-loaded nanostructured lipid carriers (NLCs): strategy to overcome oral delivery drawbacks
por: Elmowafy, Mohammed, et al.
Publicado: (2017)

Nanostructured Lipid Carriers (NLCs) for Oral Peptide Drug Delivery: About the Impact of Surface Decoration
por: Shahzadi, Iram, et al.
Publicado: (2021)

SN38 loaded nanostructured lipid carriers (NLCs); preparation and in vitro evaluations against glioblastoma
por: Shirazi, Ali Sabouri, et al.
Publicado: (2021)

In vivo evaluation of nanostructured lipid carrier systems (NLCs) in mice bearing prostate cancer tumours
por: Akanda, Mushfiq, et al.
Publicado: (2021)

Development of a Cyclodextrin-Based Mucoadhesive-Thermosensitive In Situ Gel for Clonazepam Intranasal Delivery
por: Cirri, Marzia, et al.
Publicado: (2021)

β-Sitosterol Loaded Nanostructured Lipid Carrier: Physical and Oxidative Stability, In Vitro Simulated Digestion and Hypocholesterolemic Activity
por: Soleimanian, Yasamin, et al.
Publicado: (2020)

Tablets of “Hydrochlorothiazide in Cyclodextrin in Nanoclay”: A New Nanohybrid System with Enhanced Dissolution Properties
por: Maestrelli, Francesca, et al.
Publicado: (2020)

Folate-Targeted Nanostructured Lipid Carriers (NLCs) Enhance (Letrozol) Efficacy in MCF-7 Breast Cancer Cells
por: Sabzichi, Mehdi, et al.
Publicado: (2016)

Development of Triamcinolone Acetonide-Loaded Nanostructured Lipid Carriers (NLCs) for Buccal Drug Delivery Using the Box-Behnken Design
por: Kraisit, Pakorn, et al.
Publicado: (2018)

Cannabidiol-Loaded Nanostructured Lipid Carriers (NLCs) for Dermal Delivery: Enhancement of Photostability, Cell Viability, and Anti-Inflammatory Activity
por: Morakul, Boontida, et al.
Publicado: (2023)

Preparation and Characterization of Undecylenoyl Phenylalanine Loaded-Nanostructure Lipid Carriers (NLCs) as a New α-MSH Antagonist and Antityrosinase Agent
por: Vaziri, Mohadeseh Sadat, et al.
Publicado: (2023)

Nanostructured Lipid Carriers Can Enhance Oral Absorption of Khellin, a Natural Pleiotropic Molecule
por: Vanti, Giulia, et al.
Publicado: (2021)

Generation of a novel human dermal substitute functionalized with antibiotic-loaded nanostructured lipid carriers (NLCs) with antimicrobial properties for tissue engineering
por: Chato-Astrain, Jesús, et al.
Publicado: (2020)

Formulation and characterization of hydrochlorothiazide solid lipid microparticles based on lipid matrices of Irvingia fat
por: Agubata, Chukwuma O., et al.
Publicado: (2014)

Formulation and in vitro characterization of domperidone loaded solid lipid nanoparticles and nanostructured lipid carriers
por: Thatipamula, RP., et al.
Publicado: (2011)

Multiple Roles of Chitosan in Mucosal Drug Delivery: An Updated Review
por: Mura, Paola, et al.
Publicado: (2022)

In Vitro Studies on Nasal Formulations of Nanostructured Lipid Carriers (NLC) and Solid Lipid Nanoparticles (SLN)
por: Costa, Cláudia Pina, et al.
Publicado: (2021)

Development of a Mosquito Repellent Formulation Based on Nanostructured Lipid Carriers
por: Abrantes, Daniele Carvalho, et al.
Publicado: (2021)

Effect of Palm or Coconut Solid Lipid Nanoparticles (SLNs) on Growth of Lactobacillus plantarum in Milk
por: Jo, Yeon-Ji, et al.
Publicado: (2015)

A pre-formulation study of tetracaine loaded in optimized nanostructured lipid carriers
por: Castro, Simone R., et al.
Publicado: (2021)

Solid Lipid Nanoparticles (SLNs): An Advanced Drug Delivery System Targeting Brain through BBB
por: Satapathy, Mantosh Kumar, et al.
Publicado: (2021)

Development and Characterization of Cyclodextrin-Based Nanogels as a New Ibuprofen Cutaneous Delivery System
por: Cirri, Marzia, et al.
Publicado: (2022)

Antineoplastics Encapsulated in Nanostructured Lipid Carriers
por: Rodrigues da Silva, Gustavo Henrique, et al.
Publicado: (2021)

Ocular Formulation Based on Palmitoylethanolamide-Loaded Nanostructured Lipid Carriers: Technological and Pharmacological Profile
por: Puglia, Carmelo, et al.
Publicado: (2020)

Nanostructured Lipid Carriers for the Formulation of Topical Anti-Inflammatory Nanomedicines Based on Natural Substances
por: Ferreira, Kézia Cristine Barbosa, et al.
Publicado: (2021)

Role of Cyclodextrins and Drug Solid State Properties on Flufenamic Acid Dissolution Performance from Tablets
por: Maestrelli, Francesca, et al.
Publicado: (2022)

Hydrochlorothiazide Use and Risk of Nonmelanoma Skin Cancers: A Biological Plausibility Study
por: Bigagli, Elisabetta, et al.
Publicado: (2021)

An Innovative Formulation Based on Nanostructured Lipid Carriers for Imatinib Delivery: Pre-Formulation, Cellular Uptake and Cytotoxicity Studies
por: Gundogdu, Evren, et al.
Publicado: (2022)

Formulation of Cannabidiol in Colloidal Lipid Carriers
por: Francke, Nadine Monika, et al.
Publicado: (2021)

Formulation design, preparation, and in vitro and in vivo characterizations of β-Elemene-loaded nanostructured lipid carriers
por: Shi, Feng, et al.
Publicado: (2013)

Formulation of Menthol-Loaded Nanostructured Lipid Carriers to Enhance Its Antimicrobial Activity for Food Preservation
por: Piran, Parizad, et al.
Publicado: (2017)

Compritol-Based Nanostrucutured Lipid Carriers (NLCs) for Augmentation of Zolmitriptan Bioavailability via the Transdermal Route: In Vitro Optimization, Ex Vivo Permeation, In Vivo Pharmacokinetic Study
por: Hassan, Doaa H., et al.
Publicado: (2022)

Formulation design, production and characterisation of solid lipid nanoparticles (SLN) and nanostructured lipid carriers (NLC) for the encapsulation of a model hydrophobic active
por: Sakellari, Georgia I., et al.
Publicado: (2021)

Physicochemical Characteristics and In Vitro Toxicity/Anti-SARS-CoV-2 Activity of Favipiravir Solid Lipid Nanoparticles (SLNs)
por: Tulbah, Alaa S., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_jucgqmlvf1g9tp97otah3rr8mk